#pharma #pricing #policy #healthcare
Johnson & Johnson inks a voluntary deal with the Trump Administration to lower drug prices, align U.S. pricing with Europe, and boost domestic manufacturing.
#healthcare #pharma #pricing #obesity
Eli Lilly trims Zepbound vial prices to $499/month for self-pay patients, signaling broader obesity drug affordability amid industry and political pushes.
#pfizer #metsera #obesity #biotech #pharma
Pfizer secures a $10B deal to acquire Metsera, boosting obesity therapies and signaling strategic growth in biotech.
#tariffs #pharma #trade #healthcare #uk_us
The US and UK strike zero-tariff pharma exports deal, boosting patient access and UK life sciences investment.
#health #pharma #recall #fda #global_supply_chain
Massive recall of atorvastatin due to dissolution failures raises FDA oversight and global supply chain concerns.
#trump #pharma #tariffs #healthcare #policy
Explores Trump's 100% tariffs on foreign drugs, potential price spikes, supply concerns, and impact on patients needing essential medications.
